Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management, and Cardiovascular Issues in Pregnancy.
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
A long-term follow-up study of sotatercept for treatment of pulmonary arterial hypertension: interim results of SOTERIA
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies
Pericardial effusion in sotatercept phase 3 trials: insights from STELLAR and ZENITH
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic
Risk stratification in pulmonary arterial hypertension using Bayesian analysis
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Impact of Severe Pulmonary Arterial Hypertension on the Left Heart and Prognostic Implications
Long‐term results of the DelIVery for Pulmonary Arterial Hypertension trial
Clinical trial design and new therapies for pulmonary arterial hypertension
Heart Failure With Preserved Ejection Fraction Expert Panel Report
Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System
Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension
Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension
Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension
Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension
Cardiac MRI right ventricle / left ventricle (RV/LV) volume ratio improves detection of RV enlargement
CT-Based Pulmonary Artery Measurements for the Assessment of Pulmonary Hypertension
Right Ventricular Strain in Pulmonary Arterial Hypertension: A 2D Echocardiography and Cardiac Magnetic Resonance Study
β-Blocker Therapy Is Not Associated With Adverse Outcomes in Patients With Pulmonary Arterial Hypertension